NCT01021761 - A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification | Biotech Hunter

Enrollment

126

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

January 31, 2010

Conditions

Cataracts

Interventions

DRUG

Ketorolac Tromethamine

ketorolac to be given 1 drop BID the day before surgery and 3 doses pre op the day of surgery prior to surgery

DRUG

Bromfenac

Drug to be given 1 drop BID the day before surgery and 3 doses pre op the day of surgery prior to surgery

DRUG

nepafenac

drug to be given 1 drop BID the day before surgery and 3 doses pre op the day of surgery prior to surgery